RAPT - RAPT Therapeutics announces proposed public offering
2025-10-21 16:17:11 ET
More on RAPT Therapeutics
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria - Slideshow
- RAPT Therapeutics, Inc. (RAPT) Discusses Top Line Phase II Results for RPT-904 in Chronic Spontaneous Urticaria Transcript
- RAPT Therapeutics jumps on mid-stage data for urticaria candidate
- Seeking Alpha’s Quant Rating on RAPT Therapeutics
- Historical earnings data for RAPT Therapeutics